Primary non-Hodgkin's lymphoma of the lung

被引:216
作者
Ferraro, P
Trastek, VF
Adlakha, H
Deschamps, C
Allen, MS
Pairolero, PC
机构
[1] Mayo Clin & Mayo Fdn, Div Gen Thorac Surg, Dept Surg, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Pathol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S0003-4975(99)01535-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. primary non-Hodgkin's lymphoma of the lung is a rare entity. Although the prognosis is favorable, clinical features, prognostic factors, and patient management have not been clearly defined. Methods. We reviewed retrospectively the records of 48 patients operated on for primary pulmonary non-Hodgkin's lymphoma. The study group consisted of 21 male (44%) and 27 female (56%) patients with a mean age of 61.8 years. Thirty-seven and a half percent of patients were asymptomatic, and 62.5% were seen with pulmonary symptoms, systemic symptoms, or both. A definitive diagnosis was obtained by thoracotomy in 90% of patients, thoracoscopy in 8%, and anterior mediastinotomy in 2%. Results. Complete surgical resection was possible in 19 patients (40%). A mucosa-associated lymphoid tissue lymphoma (MALT) was found in 35 patients and lymphoma that was not of this type, in 13. The 1-year, 5-year, and 10-year survival rates were 91%, 68%, and 53%, respectively in the group with mucosa-associated lymphoid tissue lymphoma and 85%, 65%, and 64% in the group with lymphoma that was not of the mucosa-associated lymphoid tissue type. None of the prognostic factors studied (mode of presentation, smoking history, bilateral disease, postoperative stage, complete resection, adjuvant chemotherapy, histology) significantly influenced patient survival. Conclusions. Primary non-Hodgkin's lymphoma of the lung occurs with nonspecific clinical features. Although patient survival is good, prognostic factors could not be identified. (C) 2000 by The Society of Thoracic Surgeons.
引用
收藏
页码:993 / 997
页数:5
相关论文
共 26 条
  • [1] REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION
    BAYERDORFFER, E
    NEUBAUER, A
    RUDOLPH, B
    THIEDE, C
    LEHN, N
    EIDT, S
    STOLTE, M
    [J]. LANCET, 1995, 345 (8965): : 1591 - 1594
  • [2] BIENENSTOCK J, 1973, LAB INVEST, V28, P686
  • [3] PULMONARY LYMPHOMAS - CURRENT CONCEPTS
    COLBY, TV
    CARRINGTON, CB
    [J]. HUMAN PATHOLOGY, 1983, 14 (10) : 884 - 887
  • [4] PRIMARY PULMONARY LYMPHOMAS - A CLINICAL-STUDY OF 70 CASES IN NONIMMUNOCOMPROMISED PATIENTS
    CORDIER, JF
    CHAILLEUX, E
    LAUQUE, D
    REYNAUDGAUBERT, M
    DIETEMANNMOLARD, A
    DALPHIN, JC
    BLANCJOUVAN, F
    LOIRE, R
    [J]. CHEST, 1993, 103 (01) : 201 - 208
  • [5] DETECTION OF PULMONARY LYMPHOMA BY BRONCHOALVEOLAR LAVAGE
    DAVIS, WB
    GADEK, JE
    [J]. CHEST, 1987, 91 (05) : 787 - 790
  • [6] DECASTRO FR, 1995, RESPIRATION, V62, P359
  • [7] A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    FISHER, RI
    DAHLBERG, S
    NATHWANI, BN
    BANKS, PM
    MILLER, TP
    GROGAN, TM
    [J]. BLOOD, 1995, 85 (04) : 1075 - 1082
  • [8] HARRIS NL, 1994, BLOOD, V84, P1361
  • [9] ISAACSON P, 1984, CANCER, V53, P2515, DOI 10.1002/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO
  • [10] 2-C